Healthcare Providers and Services
Company Overview of Brigham and Women's Hospital
Brigham and Women's Hospital, an academic medical center, operates inpatient and outpatient facilities, clinics, primary care health centers, and diagnostic and treatment technologies and research laboratories. It provides clinical, translational, bench, and population-based research studies, including nurses health studies, physicians health studies, and the women's health initiatives. The company also offers cardiovascular medicine, neurology, neurosurgery, newborn medicine, obstetrics and gynecology, orthopedic surgery, pathology, psychiatry, radiation oncology, radiology, surgery, women’s health, arthritis and rheumatic disorders, orthopedics, pain management, dermatology, emergency medi...
75 Francis Street
Boston, MA 02115
Founded in 1980
Key Executives for Brigham and Women's Hospital
Chief Operating Officer and Executive Vice President
Senior Vice President of Communication and Public Affairs
Director of Public Affairs
Compensation as of Fiscal Year 2013.
Brigham and Women's Hospital Key Developments
Brigham and Women's Hospital Presents at BioPharm America 2013, Sep-17-2013 04:00 PM
Sep 14 13
Brigham and Women's Hospital Presents at BioPharm America 2013, Sep-17-2013 04:00 PM. Venue: Westin Boston Waterfront Hotel, Boston, Massachusetts, United States. Speakers: David Silbersweig, MD, Chairman, Department of Psychiatry, Co-Director, Institute for the Neuroscience.
Brigham and Women's Hospital Presents at Citi 8th Annual Biotech Conference, Sep-03-2013 03:00 PM
Aug 31 13
Brigham and Women's Hospital Presents at Citi 8th Annual Biotech Conference, Sep-03-2013 03:00 PM. Venue: The Mandarin Oriental Boston, 776 Boylston Street, Boston, MA 02119, United States. Speakers: Howard L. Weiner, MD, Director & Founder of the Partners Multiple Sclerosis Center & Co-Director of the Center for Neurologic Diseases.
MYOS Corp. Collaborates with Brigham and Women's Hospital to Study Synergistic Effects of Myostatin Inhibition on Testosterone-Mediated Muscle Growth
Aug 15 13
MYOS Corporation announced that it will collaborate with Brigham and Women's Hospital, a teaching affiliate of Harvard Medical School, to conduct a pre-clinical study of the effects of myostatin inhibition by orally administered MYO-T12(R) on muscle tissue and body composition in conjunction with testosterone treatment. Testosterone replacement/supplementation therapy is gaining broad recognition as an effective treatment for hypogonadism in men. One of the most prominent effects of testosterone therapy is improved muscle mass and muscle strength. Augmenting those muscle gains with a safe and effective oral myostatin inhibitor in the form of a dietary supplement may provide an important adjunct to testosterone therapy.
Similar Private Companies By Industry
Recent Private Companies Transactions